Intrinsic resistance to ROS1 inhibition in a patient with CD74-ROS1 mediated by AXL overexpression.
Tara L PetersNan ChenLogan C TylerAnh T LeAnastasios DimouRobert C DoebelePublished in: Thoracic cancer (2023)
In summary, we demonstrate that AXL overexpression is a mechanism of intrinsic resistance to ROS1 inhibitors.